Roman P. Simon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Roman P. Simon has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
Wolfgang Reindl
Drug Discovery Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riß, Germany
3 shared publicationsYuting Wang
Drug Discovery Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riß, Germany
3 shared publicationsAchim Grube
Department of Drug Discovery Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, 88397 Biberach an der Riß, Germany
2 shared publications- Amaury Ernesto Fernández‐Montalván
Drug Discovery Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riß, Germany
2 shared publications Andreas H. Luippold
Drug Discovery Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riß, Germany
2 shared publicationsChristoph Saal
Department of Drug Discovery Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, 88397 Biberach an der Riß, Germany
2 shared publications
Latest Publications
- Open Access
- 22 October 2025
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 217, 107346
Design of an in situ forming methylcellulose hydrogel as universal vehicle for preclinical intravitreal injection of particulate formulations
- 22 October 2025
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 217, 107346
Open AccessDesign of an in situ forming methylcellulose hydrogel as universal vehicle for preclinical intravitreal injection of particulate formulations
- Open Access
- 5 March 2025
- Published by Elsevier in Journal of Controlled Release
- Vol. 381, 113602
Surface-coated silica microparticles: In vitro and ex vivo evaluation of a preclinical extended release platform conceived for intravitreal injection
- 5 March 2025
- Published by Elsevier in Journal of Controlled Release
- Vol. 381, 113602
Open AccessSurface-coated silica microparticles: In vitro and ex vivo evaluation of a preclinical extended release platform conceived for intravitreal injection
- Open Access
- 8 April 2023
- Published by Elsevier in SLAS Discovery
- Vol. 28 (5) , 240-246
Label-free high-throughput screening via acoustic ejection mass spectrometry put into practice
- 8 April 2023
- Published by Elsevier in SLAS Discovery
- Vol. 28 (5) , 240-246
Open AccessLabel-free high-throughput screening via acoustic ejection mass spectrometry put into practice
- Open Access
- 18 May 2022
- Published by Elsevier in SLAS Discovery
- Vol. 27 (5) , 287-297
Differential analyte derivatization enables unbiased MALDI-TOF-based high-throughput screening: A proof-of-concept study for the discovery of catechol-o-methyltransferase inhibitors
- 18 May 2022
- Published by Elsevier in SLAS Discovery
- Vol. 27 (5) , 287-297
Open AccessDifferential analyte derivatization enables unbiased MALDI-TOF-based high-throughput screening: A proof-of-concept study for the discovery of catechol-o-methyltransferase inhibitors
- Open Access
- 1 September 2021
- Published by Elsevier in SLAS Discovery
- Vol. 26 (8) , 961-973
Acoustic Ejection Mass Spectrometry: A Fully Automatable Technology for High-Throughput Screening in Drug Discovery
- 1 September 2021
- Published by Elsevier in SLAS Discovery
- Vol. 26 (8) , 961-973
Open AccessAcoustic Ejection Mass Spectrometry: A Fully Automatable Technology for High-Throughput Screening in Drug Discovery